STOCK TITAN

UPST Form 4: CEO’s $2.5M pre-planned sale, ownership still >10M shares

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Form 4 snapshot: On 06/20/2025, Upstart Holdings, Inc. (UPST) Chief Executive Officer and 10% owner Dave Girouard exercised 41,667 fully-vested options at an exercise price of $0.83 and, under a previously adopted Rule 10b5-1 trading plan, sold the same 41,667 common shares at a weighted-average price of $60.0471.

Transaction value: The exercise cost was roughly $34.6 k, while the sale generated about $2.5 million in gross proceeds, locking in an approximate $59.22 per-share gain.

Ownership impact: Direct holdings declined to 52,614 shares. However, Girouard still controls approximately 10.69 million shares through a series of family trusts and retains 960,076 additional vested options. The reported sale therefore represents well under 1 % of his total beneficial ownership, leaving his economic exposure largely intact.

Investor considerations:

  • The modest size relative to overall stake and the use of a 10b5-1 plan mitigate signalling risk typically associated with insider sales.
  • No new shares were issued; the exercised options were already accounted for in the fully-diluted share count, so dilution is immaterial.
  • While recurring insider selling can pressure sentiment, the CEO’s remaining double-digit percentage stake continues to align management incentives with shareholder value.

Positive

  • CEO retains ~10.7 million shares, demonstrating continued alignment with shareholders even after the sale.
  • Transaction executed under a Rule 10b5-1 plan, reducing concerns about informational advantage.

Negative

  • Insider sale of ~$2.5 million could create short-term sentiment pressure.
  • Direct share count declined by 44% (from 94,281 to 52,614), modestly lowering immediate insider ownership visibility.

Insights

TL;DR — Small pre-planned sale; neutral signal.

The CEO liquidated ~41.7 k shares for ~$2.5 m, but still controls more than 10.7 m shares plus nearly 1 m options. Because the sale was executed under a Rule 10b5-1 plan and represents a fraction of total ownership, I view the event as routine portfolio diversification rather than a bearish indicator. Share count dilution is negligible since the options were already vested and included in fully-diluted figures. Overall impact on valuation or near-term fundamentals is minimal.

TL;DR — Governance compliant, impact limited.

The filing confirms adherence to insider-trading best practices: advance 10b5-1 scheduling, detailed price disclosure, and continued substantial ownership. From a governance standpoint, transparency is adequate and alignment remains strong. Investors should monitor frequency of future sales, but this isolated, rule-compliant transaction is not inherently negative.

Insider Girouard Dave
Role Chief Executive Officer
Sold 41,667 shs ($2.50M)
Type Security Shares Price Value
Exercise Employee Stock Option (Right to buy) 41,667 $0.83 $35K
Exercise Common Stock 41,667 $0.83 $35K
Sale Common Stock 41,667 $60.0471 $2.50M
holding Common Stock -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Employee Stock Option (Right to buy) — 960,076 shares (Direct); Common Stock — 94,281 shares (Direct); Common Stock — 8,342,701 shares (Indirect, See Footnote)
Footnotes (1)
  1. The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 29, 2024. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.135. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. These shares are held by 2008 D&T Girouard Revocable Trust, for which the Reporting Person serves as Trustee. These shares are held by David J Girouard, as trustee of the DTG GRAT LLC, dated May 23, 2023. These shares are held by Tristen Baird Willard, as trustee of the TMG 2020 EXEMPT GIFT TRUST, dated October 19, 2020. These shares are held by Tristen Baird Willard, as trustee of the JRG 2020 EXEMPT GIFT TRUST, dated October 19, 2020. These shares are held by the JRG NONEXEMPT GIFT TRUST. These shares are held by Tristen Baird Willard, as trustee of the JRG 2020 NONEXEMPT GIFT TRUST, dated October 19, 2020. All of the shares subject to this option are fully vested and exercisable as of the date hereof.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Girouard Dave

(Last) (First) (Middle)
C/O UPSTART HOLDINGS, INC.
2950 S. DELAWARE STREET, SUITE 410

(Street)
SAN MATEO CA 94403

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Upstart Holdings, Inc. [ UPST ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
06/20/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/20/2025 M(1) 41,667 A $0.83 94,281 D
Common Stock 06/20/2025 S(1) 41,667 D $60.0471(2) 52,614 D
Common Stock 8,342,701 I See Footnote(3)
Common Stock 1,000,000 I See Footnote(4)
Common Stock 546,501 I See Footnote(5)
Common Stock 546,501 I See Footnote(6)
Common Stock 126,057 I See Footnote(7)
Common Stock 126,057 I See Footnote(8)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to buy) $0.83 06/20/2025 M(1) 41,667 (9) 09/20/2026 Common Stock 41,667 $0.83 960,076 D
Explanation of Responses:
1. The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 29, 2024.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.135. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
3. These shares are held by 2008 D&T Girouard Revocable Trust, for which the Reporting Person serves as Trustee.
4. These shares are held by David J Girouard, as trustee of the DTG GRAT LLC, dated May 23, 2023.
5. These shares are held by Tristen Baird Willard, as trustee of the TMG 2020 EXEMPT GIFT TRUST, dated October 19, 2020.
6. These shares are held by Tristen Baird Willard, as trustee of the JRG 2020 EXEMPT GIFT TRUST, dated October 19, 2020.
7. These shares are held by the JRG NONEXEMPT GIFT TRUST.
8. These shares are held by Tristen Baird Willard, as trustee of the JRG 2020 NONEXEMPT GIFT TRUST, dated October 19, 2020.
9. All of the shares subject to this option are fully vested and exercisable as of the date hereof.
Remarks:
/s/ Jessica Jeong, by power of attorney 06/24/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Upstart (UPST) shares did CEO Dave Girouard sell on 20 June 2025?

He sold 41,667 shares at a weighted-average price of $60.0471.

What was the exercise price of the options exercised by the UPST CEO?

The options were exercised at $0.83 per share.

Does the transaction increase Upstart's outstanding share count?

No. The options were already vested and included in fully-diluted counts, so dilution is immaterial.

How many UPST shares does the CEO still own after the sale?

He directly holds 52,614 shares and controls about 10.69 million additional shares through family trusts.

Was the sale executed under a Rule 10b5-1 trading plan?

Yes. The plan was adopted on August 29, 2024, meeting SEC safe-harbor requirements.